Xiaoli Shan
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mechanistic investigation of Guizhi Gancao decoction in alleviating isoproterenol-induced chronic heart failure via inhibition of sarcoplasmic/endoplasmic (SR/ER) reticulum Ca2+-ATPase 2a ubiquitination.
Journal: Journal of ethnopharmacology
Published: February 20, 2026
Guizhi Gancao Decoction protects against doxorubicin-induced cardiotoxicity by intervening in microtubule acetylation.
Journal: Journal of ethnopharmacology
Published: October 23, 2025
Lingguizhugan Decoction improves chronic heart failure by synergistically modulating ?1-AR/Gs/GRKs/?-arrestin signaling bias.
Journal: Chinese journal of natural medicines
Published: October 02, 2024
Stachydrine hydrochloride reduces NOX2 activity to suppress oxidative stress levels to improve cardiac insufficiency.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 18, 2024
Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy.
Journal: Pharmaceutical biology
Published: May 22, 2024
Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2.
Journal: European journal of pharmacology
Published: February 01, 2024
Stachydrine hydrochloride protects the ischemic heart by ameliorating endoplasmic reticulum stress through a SERCA2a dependent way and maintaining intracellular Ca2+ homeostasis.
Journal: European journal of pharmacology
Published: January 12, 2024
Stachydrine Hydrochloride Regulates the NOX2-ROS-Signaling Axis in Pressure-Overload-Induced Heart Failure.
Journal: International journal of molecular sciences
Published: August 25, 2023
A new mechanism of therapeutic effect of stachydrine on heart failure by inhibiting myocardial ferroptosis.
Journal: European journal of pharmacology
Published: March 28, 2023
Icariin inhibits hypertrophy by regulation of GPER1 and CaMKII/HDAC4/MEF2C signaling crosstalk in ovariectomized mice.
Journal: Chemico-biological interactions
Published: November 19, 2022
Stachytine Hydrochloride Improves Cardiac Function in Mice with ISO-Induced Heart Failure by Inhibiting the α-1,6-Fucosylation on N-Glycosylation of β1AR.
Journal: Frontiers in pharmacology
Published: December 13, 2021
Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.
Journal: BMC complementary medicine and therapies
Published: August 31, 2021
Last Updated: 09/26/2026